CYTK - Cytokinetics to Participate in March Investor Conferences | Benzinga
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the company is scheduled to participate in the following investor conferences in March:
- Leerink Global Biopharma Conference: Robert I. Blum, President and Chief Executive Officer, Andrew Callos, Executive Vice President and Chief Commercial Officer, and Fady I. Malik, Executive Vice President of Research & Development, will participate in a fireside chat on Monday, March 11, 2024 at 1:20 PM Eastern Time at the Fontainebleau Miami Beach Hotel in Miami Beach, FL.
- Jefferies Biotech on the Bay Summit: Management will participate in one-on-one meetings on Tuesday, March 12, 2024 at the W South Beach Hotel in Miami Beach, FL.
- Barclays 26th Annual Global Healthcare Conference: Robert I. Blum, President and Chief Executive Officer, Andrew Callos, Executive Vice President and Chief Commercial Officer, and Fady I. Malik, Executive Vice President of Research & Development, will participate in a fireside chat on Wednesday, March 13, 2024 at 9:00 AM Eastern Time at the Loews Miami Beach Hotel in Miami Beach, FL.
Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at